Prevalence of antiphospholipid antibodies and risk of subsequent adverse obstetric outcomes in women with prior pregnancy loss

Journal of Reproductive Immunology

Volumn 107, Issue , 2015, Pages 59-63

  Bowman, Zachary S ^a   Wünsche, Vera ^a   Porter, T Flint ^a   Silver, Robert M ^a   Branch, D Ware ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Antiphospholipid antibodies; Pregnancy risk; Recurrent pregnancy loss; Systemic lupus erythematosus; Venous thromboembolism

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ADVERSE OUTCOME; ANTIBODY TITER; ARTICLE; DELIVERY; FEMALE; FETUS WASTAGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VENOUS THROMBOEMBOLISM; BLOOD; IMMUNOLOGY; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDY;

ABORTION, SPONTANEOUS; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM;

EID: 84921048179     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2014.09.052     Document Type: Article

References (17)

1. Andreoli L., Chighizola C.B., Banzato A., Pons-Estel G.J., De Jesus G.R., Erkan D., On Behalf Of A.A. The estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis. Arthritis Care Res. (Hoboken) 2013, 65:1869-1873.
2. Bramham K., Hunt B.J., Germain S., Calatayud I., Khamashta M., Bewley S., Nelson-Piercy C. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus 2010, 19:58-64.
3. Branch D.W., Silver R.M., Blackwell J.L., Reading J.C., Scott J.R. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet. Gynecol. 1992, 80:614-620.
4. Branch D.W., Peaceman A.M., Druzin M., Silver R.K., El-Sayed Y., Silver R.M., Esplin M.S., Spinnato J., Harger J. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am. J. Obstet. Gynecol. 2000, 182:122-127.
5. Branch D.W., Gibson M., Silver R.M. Clinical practice. Recurrent miscarriage. N. Engl. J. Med. 2010, 363:1740-1747.
6. Clark C.A., Davidovits J., Spitzer K.A., Laskin C.A. The lupus anticoagulant: results from 2257 patients attending a high-risk pregnancy clinic. Blood 2013, 122:341-347. quiz 466.
7. Committee on Practice Bulletins-Obstetrics, A.C.O.O.& Gynecologists Practice Bulletin No. 132: antiphospholipid syndrome. Obstet. Gynecol. 2012, 120:1514-1521.
8. De Jesus G.R., Agmon-Levin N., Andrade C.A., Andreoli L., Chighizola C.B., Flint Porter T., Salmon J., Silver R.M., Tincani A., Ware Branch D. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome. Autoimmun. Rev. 2014, 13:795-813.
9. Franssen M.T., Korevaar J.C., Leschot N.J., Bossuyt P.M., Knegt A.C., Gerssen-Schoorl K.B., Wouters C.H., Hansson K.B., Hochstenbach R., Madan K., Van Der Veen F., Goddijn M. Selective chromosome analysis in couples with two or more miscarriages: case-control study. BMJ 2005, 331:137-141.
10. Lockshin M.D., Kim M., Laskin C.A., Guerra M., Branch D.W., Merrill J., Petri M., Porter T.F., Sammaritano L., Stephenson M.D., Buyon J., Salmon J.E. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum. 2012, 64:2311-2318.
11. Mak A., Cheung M.W., Cheak A.A., Ho R.C. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression. Rheumatology (Oxford) 2010, 49:281-288.
12. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., Derksen R.H., Pg D.E.G., Koike T., Meroni P.L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P.G., Krilis S.A. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 2006, 4:295-306.
13. Rai R.S., Regan L., Clifford K., Pickering W., Dave M., Mackie I., Mcnally T., Cohen H. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum. Reprod. 1995, 10:2001-2005.
14. Reindollar R.H. Contemporary issues for spontaneous abortion. Does recurrent abortion exist?. Obstet. Gynecol. Clin. North Am. 2000, 27:541-554.
15. Royal College of Obstetricians and Gynaecologists Recurrent Miscarriage, Investigation and Treatment of Couples. Green-Top Guideline No. 17 2011, RCOG, London.
16. Salat-Baroux J. [Recurrent spontaneous abortions]. Reprod. Nutr. Dev. 1988, 28:1555-1568.
17. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., Brey R., Derksen R., Harris E.N., Hughes G.R., Triplett D.A., Khamashta M.A. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999, 42:1309-1311.